Calendrier des promotions Collegium Pharmaceutical, Inc.
Calendrier avancé
Graphique simple
À propos de l'entreprise Collegium Pharmaceutical, Inc.
Collegium Pharmaceutical, Inc., специализированная фармацевтическая компания, разрабатывает и продает различные продукты для пациентов, страдающих от боли. Он предоставляет технологию платформы DETERx, которая предназначена для поддержания профилей пролонгированного высвобождения и безопасности часто используемых наркотиков перед лицом различных методов злоупотребления и неправильного использования, включая жевание, дробление и инъекцию. plus de détailsParamètres de base
IPO date
2015-05-07
ISIN
US19459J1043
Industry
Pharmaceuticals
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Див.доход ао
0
Сайт
Grade
Sous-estimation
| Nom | Signification | Grade |
| P/S | 1.83 | 8 |
| P/BV | 5.05 | 3 |
| P/E | 16.72 | 7 |
Efficacité
| Nom | Signification | Grade |
| ROA | 4.93 | 1 |
| ROE | 32.62 | 9 |
| ROIC | 7.71 | 2 |
Dividendes
| Nom | Signification | Grade |
| Rendement en dividendes | 0 | 0 |
| DSI | 0 | 0 |
| Croissance moyenne du dividende | 0 | 0 |
Devoir
| Nom | Signification | Grade |
| Debt/EBITDA | 2.51 | 5 |
| Debt/Ratio | 0.5165 | 9 |
| Debt/Equity | 3.75 | 3 |
Impulsion de croissance
| Nom | Signification | Grade |
| Rentabilité Revenue, % | 103.69 | 10 |
| Rentabilité Ebitda, % | 504.78 | 10 |
| Rentabilité EPS, % | 124.88 | 10 |
paper.price.prices
| Prix | Common.min. | Common.max. | Changement | paper.changes_in_industry | paper.changes_in_index | |
| common.calendar.number_days.1 | 29.6 $ | 0 $ | 0 $ | 0 % | 0 % | 0 % |
| common.calendar.number_days.7d | 30.2 $ | 29.6 $ | 30.44 $ | -1.99 % | 0 % | 0 % |
| common.calendar.number_days.30d | 28.82 $ | 28.82 $ | 30.44 $ | 2.71 % | 0 % | 0 % |
| common.calendar.number_days.90d | 26.37 $ | 24.67 $ | 30.56 $ | 12.25 % | 0 % | 0 % |
| common.calendar.number_days.180d | 30.93 $ | 24.67 $ | 33.91 $ | -4.3 % | 0 % | 0 % |
| common.calendar.number_days.1y | 37.79 $ | 24.67 $ | 41.86 $ | -21.67 % | 0 % | 0 % |
| common.calendar.number_days.3y | 16.83 $ | 15.46 $ | 41.86 $ | 75.88 % | 0 % | 0 % |
| common.calendar.number_days.5y | 18.84 $ | 14.22 $ | 41.86 $ | 57.11 % | 0 % | 0 % |
| common.calendar.number_days.10y | 19.41 $ | 8.1 $ | 41.86 $ | 52.5 % | 0 % | 0 % |
| common.calendar.number_days.ytd | 29.66 $ | 24.67 $ | 33.91 $ | -0.2 % | 0 % | 0 % |
Principaux propriétaires
Contenu dans l'ETF
| ETF | Partager, % | Rentabilité pour l'année, % | Commission, % |
| AXS FOMO ETF | 2.64 | 0 | 0.90 |
| Syntax Stratified SmallCap ETF | 0.21251 | -2.2 | 0.40 |
| Future Tech ETF | 0.12399 | -18.13 | 0.35 |
| Principal Healthcare Innovators ETF | 0.12399 | -3.92 | 0.35 |
| iShares Morningstar Small-Cap Value ETF | 0.0545 | 173.73 | 0.06 |
| iShares Morningstar Small-Cap ETF | 0.02706 | 295.15 | 0.25 |
| 0,53 | 74,11 | 0,39 |
|---|
Entreprises similaires
P/E & P/BV
Gestion d'entreprise
| Superviseur | Titre d'emploi | Paiement | Année de naissance |
| Ms. Shirley R. Kuhlmann | Executive VP, General Counsel, Chief Administrative Officer & Secretary | 842.9k | 1984 (41 année) |
| Ms. Colleen Tupper | Executive VP & CFO | 848.29k | 1976 (49 années) |
| Mr. Bart J. Dunn | Executive Vice President of Strategy & Corporate Development | N/A | |
| Mr. Scott Dreyer | Executive VP & Chief Commercial Officer | 746.58k | 1972 (53 année) |
| Mr. Michael Thomas Heffernan B.S. Pharm, R.Ph. | Co-Founder, Chairman, Interim CEO & President | 110k | 1964 (61 année) |
| Mr. Scott Sudduth | Head of Technical Operations | N/A | |
| Dr. Christopher Shayne James M.D. | Vice President of Investor Relations | N/A | |
| Dr. Thomas B. Smith FAAFP, M.D. | Executive VP & Chief Medical Officer | 692.91k | 1961 (64 année) |
Informations sur l'entreprise
Adresse: United States, Stoughton, 100 Technology Center Drive - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.collegiumpharma.com
Site web: https://www.collegiumpharma.com
